- ZLAB Dashboard
-
Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Zai Lab Limited (ZLAB) Financial statements
Company Profile
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | ||
---|---|---|---|---|---|---|---|---|
Total Revenue | ||||||||
Cost of Revenue | ||||||||
Gross Profit | ||||||||
Gross Profit Margin (%) | ||||||||
R&D Expense | ||||||||
SG&A Expense | ||||||||
Total Operating Expenses | ||||||||
Operating Income or Loss | ||||||||
Operating Margin (%) | ||||||||
Interest Expense | ||||||||
Total Other Income/Expenses | ||||||||
Income Before Tax | ||||||||
Income Tax Expense | ||||||||
Income from Continuing Ops. | ||||||||
Net Income | ||||||||
Net Profit Margin (%) | ||||||||
Net Income Available to Common Shareholders | ||||||||
Basic EPS | ||||||||
Diluted EPS | ||||||||
Basic Average Shares | ||||||||
Diluted Average Shares |
Sep 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | ||||||||||||||||||
Cost of Revenue | ||||||||||||||||||
Gross Profit | ||||||||||||||||||
Gross Profit Margin (%) | ||||||||||||||||||
R&D Expense | ||||||||||||||||||
SG&A Expense | ||||||||||||||||||
Total Operating Expenses | ||||||||||||||||||
Operating Income or Loss | ||||||||||||||||||
Operating Margin (%) | ||||||||||||||||||
Interest Expense | ||||||||||||||||||
Total Other Income/Expenses | ||||||||||||||||||
Income Before Tax | ||||||||||||||||||
Income Tax Expense | ||||||||||||||||||
Income from Continuing Ops. | ||||||||||||||||||
Net Income | ||||||||||||||||||
Net Profit Margin (%) | ||||||||||||||||||
Net Income Available to Common Shareholders | ||||||||||||||||||
Basic EPS | ||||||||||||||||||
Diluted EPS | ||||||||||||||||||
Basic Average Shares | ||||||||||||||||||
Diluted Average Shares |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | ||
---|---|---|---|---|---|---|---|---|
Current Assets | ||||||||
Cash & Cash Equivalents | ||||||||
Marketable Securities | ||||||||
Receivables | ||||||||
Inventories | ||||||||
Other Current Assets | ||||||||
Total Current Assets | ||||||||
Non-Current Assets | ||||||||
Marketable Securities | ||||||||
PPE Net | ||||||||
Intangibles inc. Goodwill | ||||||||
Other Non-Current Assets | ||||||||
Total Non-Current Assets | ||||||||
Total Assets | ||||||||
Current Liabilities | ||||||||
Accounts Payable | ||||||||
Deferred Revenues | ||||||||
Debt, Current | ||||||||
Accrued Liabilities | ||||||||
Other Current Liabilities | ||||||||
Total Current Liabilities | ||||||||
Non-Current Liabilities | ||||||||
Deferred Revenues | ||||||||
Debt, Non-Current | ||||||||
Other Non-Current Liabilities | ||||||||
Total Non-Current Liabilities | ||||||||
Total Liabilities | ||||||||
Shareholders' Equity | ||||||||
Common Stock | ||||||||
Additional Paid-In Capital | ||||||||
Retained Earnings | ||||||||
Other Shareholders' Equity | ||||||||
Total Shareholders' Equity | ||||||||
Total Liabilities & Shareholders' Equity |
Sep 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Current Assets | ||||||||||||||||||
Cash & Cash Equivalents | ||||||||||||||||||
Marketable Securities | ||||||||||||||||||
Receivables | ||||||||||||||||||
Inventories | ||||||||||||||||||
Other Current Assets | ||||||||||||||||||
Total Current Assets | ||||||||||||||||||
Non-Current Assets | ||||||||||||||||||
Marketable Securities | ||||||||||||||||||
PPE Net | ||||||||||||||||||
Intangibles inc. Goodwill | ||||||||||||||||||
Other Non-Current Assets | ||||||||||||||||||
Total Non-Current Assets | ||||||||||||||||||
Total Assets | ||||||||||||||||||
Current Liabilities | ||||||||||||||||||
Accounts Payable | ||||||||||||||||||
Deferred Revenues | ||||||||||||||||||
Debt, Current | ||||||||||||||||||
Accrued Liabilities | ||||||||||||||||||
Other Current Liabilities | ||||||||||||||||||
Total Current Liabilities | ||||||||||||||||||
Non-Current Liabilities | ||||||||||||||||||
Deferred Revenues | ||||||||||||||||||
Debt, Non-Current | ||||||||||||||||||
Other Non-Current Liabilities | ||||||||||||||||||
Total Non-Current Liabilities | ||||||||||||||||||
Total Liabilities | ||||||||||||||||||
Shareholders' Equity | ||||||||||||||||||
Common Stock | ||||||||||||||||||
Additional Paid-In Capital | ||||||||||||||||||
Retained Earnings | ||||||||||||||||||
Other Shareholders' Equity | ||||||||||||||||||
Total Shareholders' Equity | ||||||||||||||||||
Total Liabilities & Shareholders' Equity |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | ||
---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | ||||||||
Net Income | ||||||||
Depreciation & Amortization | ||||||||
Deferred Income Taxes | ||||||||
Stock Based Compensation | ||||||||
Accounts Receivable | ||||||||
Inventory | ||||||||
Accounts Payable | ||||||||
Deferred Revenue | ||||||||
Other Non-Cash | ||||||||
Operating Cash Flow | ||||||||
Cash Flows from Investing Activities | ||||||||
PPE Investments | ||||||||
Net Acquisitions | ||||||||
Purchase of Investments | ||||||||
Sale of Investments | ||||||||
Other Investing Activity | ||||||||
Investing Cash Flow | ||||||||
Cash Flows from Financing Activities | ||||||||
Debt Issued | ||||||||
Proceeds from Debt Repayment | ||||||||
Debt Repayment | ||||||||
Proceeds from Sale of Equity | ||||||||
Equity Repurchased | ||||||||
Dividend Paid | ||||||||
Other Financing Activity | ||||||||
Financing Cash Flow | ||||||||
Cash Position | ||||||||
Beginning Cash Position | ||||||||
End Cash Position | ||||||||
Change in Cash | ||||||||
Free Cash Flow | ||||||||
Operating Cash Flow | ||||||||
Capital Expenditure | ||||||||
Free Cash Flow |
Sep 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | ||||||||||||||||||
Net Income | ||||||||||||||||||
Depreciation & Amortization | ||||||||||||||||||
Deferred Income Taxes | ||||||||||||||||||
Stock Based Compensation | ||||||||||||||||||
Accounts Receivable | ||||||||||||||||||
Inventory | ||||||||||||||||||
Accounts Payable | ||||||||||||||||||
Deferred Revenue | ||||||||||||||||||
Other Non-Cash | ||||||||||||||||||
Operating Cash Flow | ||||||||||||||||||
Cash Flows from Investing Activities | ||||||||||||||||||
PPE Investments | ||||||||||||||||||
Net Acquisitions | ||||||||||||||||||
Purchase of Investments | ||||||||||||||||||
Sale of Investments | ||||||||||||||||||
Other Investing Activity | ||||||||||||||||||
Investing Cash Flow | ||||||||||||||||||
Cash Flows from Financing Activities | ||||||||||||||||||
Debt Issued | ||||||||||||||||||
Proceeds from Debt Repayment | ||||||||||||||||||
Debt Repayment | ||||||||||||||||||
Proceeds from Sale of Equity | ||||||||||||||||||
Equity Repurchased | ||||||||||||||||||
Dividend Paid | ||||||||||||||||||
Other Financing Activity | ||||||||||||||||||
Financing Cash Flow | ||||||||||||||||||
Cash Position | ||||||||||||||||||
Beginning Cash Position | ||||||||||||||||||
End Cash Position | ||||||||||||||||||
Change in Cash | ||||||||||||||||||
Free Cash Flow | ||||||||||||||||||
Operating Cash Flow | ||||||||||||||||||
Capital Expenditure | ||||||||||||||||||
Free Cash Flow |